Swarm learning for decentralized artificial intelligence in cancer histopathology.

Journal: Nature medicine
Published Date:

Abstract

Artificial intelligence (AI) can predict the presence of molecular alterations directly from routine histopathology slides. However, training robust AI systems requires large datasets for which data collection faces practical, ethical and legal obstacles. These obstacles could be overcome with swarm learning (SL), in which partners jointly train AI models while avoiding data transfer and monopolistic data governance. Here, we demonstrate the successful use of SL in large, multicentric datasets of gigapixel histopathology images from over 5,000 patients. We show that AI models trained using SL can predict BRAF mutational status and microsatellite instability directly from hematoxylin and eosin (H&E)-stained pathology slides of colorectal cancer. We trained AI models on three patient cohorts from Northern Ireland, Germany and the United States, and validated the prediction performance in two independent datasets from the United Kingdom. Our data show that SL-trained AI models outperform most locally trained models, and perform on par with models that are trained on the merged datasets. In addition, we show that SL-based AI models are data efficient. In the future, SL can be used to train distributed AI models for any histopathology image analysis task, eliminating the need for data transfer.

Authors

  • Oliver Lester Saldanha
    Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Philip Quirke
    Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
  • Nicholas P West
    Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
  • Jacqueline A James
    Precision Medicine Centre of Excellence, Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Belfast, UK.
  • Maurice B Loughrey
    The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Heike I Grabsch
    Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, Netherlands.
  • Manuel Salto-Tellez
    Integrated Pathology Unit, Division of Molecular Pathology, The Institute of Cancer Research London and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
  • Elizabeth Alwers
    Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
  • Didem Cifci
    Department of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074, Aachen, Germany.
  • Narmin Ghaffari Laleh
    Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Tobias Seibel
    Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Richard Gray
    School of Nursing and Midwifery, La Trobe University, Victoria, Australia.
  • Gordon G A Hutchins
    Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
  • Hermann Brenner
    German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Marko van Treeck
    Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Tanwei Yuan
    Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Titus J Brinker
    National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Jenny Chang-Claude
    Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Firas Khader
    Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany.
  • Andreas Schuppert
  • Tom Luedde
    Division of Gastroenterology, Hepatology and Hepatobiliary Oncology, University Hospital RWTH Aachen, Aachen, Germany.
  • Christian Trautwein
    Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Hannah Sophie Muti
    Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Sebastian Foersch
    Institute of Pathology, University Medical Center Mainz, Mainz, Germany. Electronic address: sebastian.foersch@unimedizin-mainz.de.
  • Michael Hoffmeister
    Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Daniel Truhn
    Department of Diagnostic and Interventional Radiology, University Hospital Düsseldorf, Düsseldorf, Germany (J.S., D.B.A., S.N.); Institute of Computer Vision and Imaging, RWTH University Aachen, Pauwelsstrasse 30, 52072 Aachen, Germany (J.S., D.M.); Department of Diagnostic and Interventional Radiology, University Hospital Aachen, Aachen, Germany (D.T., M.P., F.M., C.K., S.N.); and Faculty of Mathematics and Natural Sciences, Institute of Informatics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany (S.C.).
  • Jakob Nikolas Kather
    Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.